資源 » 參考數據庫 » 客戶發表文獻

至今，GenScript的服務及產品已被Cell, Nature, Science, PNAS等1300多家生物醫藥類雜志引用近萬次，處于行業領先水平。NIH、哈佛、耶魯、斯坦福、普林斯頓、杜克大學等約400家全球著名機構使用GenScript的基因合成、多肽服務、抗體服務和蛋白服務等成功地發表科研成果，再次證明GenScript 有能力幫助業內科學家Make research easy.

Altered thymic CD4 T-cell recovery after allogeneic hematopoietic stem cell transplantation is critical for nocardiosis.

Curr Res Transl Med. 2019-06;

RousselXavier，DaguindauEtienne，BerceanuAna，DesbrossesYohan，SaasPhilippe，FerrandChristophe，SeillesEstelle，PouthierFabienne，DeconinckEric，LarosaFab

Products/Services Used	Details	Operation
Proteins, Expression, Isolation and Analysis	… The remaining cells were rested for 3 days in 24-well plates with 40 IU/ml IL-2 (Genscript inc., Piscataway, NJ, USA) and irradiated (30Gy) autologous feeder cells at a ratio of 1:1 before assessment of anti-viral responses using tetramer staining, ELISPOT, cytotoxicity and …	Get A Quote

摘要

Nocardia affects immunocompromised human host exhibiting an altered cell-mediated immunity. Infectious risk after allogeneic hematopoietic cell transplantation (AHCT) is significantly correlated to the recovery status of donor-derived immune system， especially CD4 T-cells reconstitution and thymopoiesis. The purpose of this paper is to highlight a lack of cell-mediated immunity recovery for patients presenting a nocardiosis compared to a control cohort.